Patient
SITE009-0162
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE009 (AUS) (Dr. Novak)
consented 2026-03-22
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
mild
assessed
2026-08-30
Grade 1 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-02-23 (study day 154); relationship: not assessed
mild
assessed
2026-06-02
Grade 1 Fatigue — outcome: RECOVERED/RESOLVED; onset 2022-11-26 (study day 65); relationship: RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.